Clinical Trials Results - National Cancer Institute

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -7 of 7 Show results per page	View Search Criteria \| Help With Results


1.		Mistletoe Extract in Early or Advanced Breast Cancer, a Randomized Feasibility Study

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase IV				Biomarker/Laboratory analysis, Treatment				Closed				18 and over				Other				WD 40 NCT00176046

Last Modified: 11/1/1993


2.		Phase III Randomized Trial of Adjuvant Treatment with IFN-A vs IFN-G vs Mistletoe Extract (Iscador M) vs No Further Treatment Following Curative Resection of High-Risk Stage I/IIB Malignant Melanoma (Summary Last Modified 11/93)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				18 to 80								EORTC-DKG-80-1

Last Modified: 5/12/2005 First Published: 11/24/2002


3.		Phase II Study of Supplemental Treatment With Mistletoe in Patients With Stage IIIB or IV Non-Small Cell Lung Cancer Receiving Palliative Chemotherapy

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 and over				NCI				TJUH-01F.45 TJUH-2001-35, NCT00052325

Last Modified: 5/8/2003 First Published: 10/1/2000


4.		Phase I Study of Mistletoe Lectin (Recombinant Viscumin) in Patients With Refractory Advanced Solid Tumors

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Closed				18 and over				Other				EORTC-16002 NCT00006354

Last Modified: 7/11/2008 First Published: 11/1/2000


5.		Phase I Study of Mistletoe Lectin (Recombinant Viscumin) in Patients With Refractory Advanced Solid Tumors

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Closed				18 and over				Other				EORTC-13001 NCT00006477

Last Modified: 8/22/2007 First Published: 11/1/2002


6.		Phase I Study of Gemcitabine and Mistletoe in Patients With Advanced Solid Tumors

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Closed				18 and over				NCCAM, NCI, Other				NCCAM-02-AT-260 NCI-02-AT-0260, NCT00049608


7.		Iscar for Second Line Treatment of Advanced Non-Small Cell Lung Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	No phase specified				Treatment				Completed				18 and over				Other				1056757 Mistletoe, NCT00283478

Select All on One Page